It has been proposed that peptides longer than nine amino acids in length have the potential to act as T-cell epitopes, triggering coeliac disease [45], with peptides of between nine and twenty-three residues in length being able to act as substrates for tissue transglutaminase [46]. The gene discussed is TGM2; the disease is celiac disease.